Enzolve to target emerging markets with infant diagnostics test kit
Enzolve Technologies has received finance from Enterprise Ireland and private investors to commence production of "NeoScreenPak", a range of diagnostic kits for screening a variety of disorders that effect newborn infants...
Read full article on the web The Market June-July 2008 or in pdf format 
Website supported by
Language Selection
